Production (Stage)
Capricor Therapeutics, Inc.
CAPR
$11.96
-$0.42-3.39%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -126.48% | -81.57% | -16.64% | 4.38% | 16.07% |
| Total Depreciation and Amortization | 28.12% | 33.33% | 42.42% | 56.43% | 74.47% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 47.47% | 33.31% | 38.70% | 47.40% | 47.97% |
| Change in Net Operating Assets | 75.30% | 8.23% | -2,029.43% | -458.44% | -313.35% |
| Cash from Operations | -45.33% | -56.25% | -76.01% | -90.76% | -108.28% |
| Capital Expenditure | 10.79% | 24.84% | 39.65% | 29.99% | 29.14% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -7,602.89% | -1,702.15% | -84.62% | 26.78% | 103.12% |
| Cash from Investing | -6,903.74% | -2,374.46% | -91.71% | 67.30% | 96.86% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 440.19% | 497.23% | 1,668.75% | 295.05% | 474.54% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 440.19% | 497.23% | 1,668.75% | 295.05% | 474.54% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 614.24% | -166.93% | 10,301.52% | 112.98% | 90.80% |